Evidence map›Paper›PMID 35264599›Full record

ArticleScientific reports2022

Efficacy of antimicrobial and anti-viral coated air filters to prevent the spread of airborne pathogens.

Rowan Watson, Morwenna Oldfield, Jack A Bryant, Lily Riordan, Harriet J Hill, Julie A Watts, Morgan R Alexander, Michael J Cox, Zania Stamataki, David J Scurr and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Role of Antimicrobial Air Purifier in Reducing the Microbial Load in the Critical Care Unit in Oncology Center: An Intervention Study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rowan WatsonInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Morwenna OldfieldInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Jack A BryantInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Lily RiordanInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Harriet J HillInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Julie A WattsAdvanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham, UK.
Morgan R AlexanderAdvanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham, UK.
Michael J CoxInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Zania StamatakiInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
David J ScurrAdvanced Materials and Healthcare Technologies Division, School of Pharmacy, University of Nottingham, Nottingham, UK.
Felicity de CoganInstitute of Microbiology and Infection, University of Birmingham, Birmingham, UK. f.decogan@bham.ac.uk.

Funding

Engineering and Physical Sciences Research Council EP/P029868/1Engineering and Physical Sciences Research Council EP/S021434/1Medical Research CouncilMedical Research Foundation MRF-169-0001-F-STAM-C0826Royal Academy of Engineering EXPP2021\1\179Wellcome Trust
6 · The paper itself

Abstract

The COVID-19 pandemic has demonstrated the real need for mechanisms to control the spread of airborne respiratory pathogens. Thus, preventing the spread of disease from pathogens has come to the forefront of the public consciousness. This has brought an increasing demand for novel technologies to prioritise clean air. In this study we report on the efficacy of novel biocide treated filters and their antimicrobial activity against bacteria, fungi and viruses. The antimicrobial filters reported here are shown to kill pathogens, such as Candida albicans, Escherichia coli and MRSA in under 15 min and to destroy SARS-CoV-2 viral particles in under 30 s following contact with the filter. Through air flow rate testing, light microscopy and SEM, the filters are shown to maintain their structure and filtration function. Further to this, the filters are shown to be extremely durable and to maintain antimicrobial activity throughout the operational lifetime of the product. Lastly, the filters have been tested in field trials onboard the UK rail network, showing excellent efficacy in reducing the burden of microbial species colonising the air conditioning system.

Indexed as

Air FiltersAnti-Infective AgentsAntiviral AgentsCandida albicansChlorhexidineCOVID-19Escherichia coliHumansMethicillin-Resistant Staphylococcus aureusSARS-CoV-2Time FactorsAnti-Infective AgentsAntiviral AgentsChlorhexidinechlorhexidine gluconate

Identifiers

PMID35264599
PMCPMC8907282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.